Stefano Del Prato discusses the advantages of tirzepatide over insulin glargine for people with type 2 diabetes, and how the SURPASS-4 findings fit with those of the rest of the clinical trial program.
View more on on the SURPASS trials on Medicine Matters diabetes: [ Ссылка ] and remember to Like this video and Subscribe to our channel
